Shareholders' equity (Tables)

12 Months Ended

Dec. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of Status of Options

	December 31, 2023
	Number of share options			Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at the beginning of the year		3,096,214			52.54		5.10
Granted		711,272			34.21
Exercised		(363,291	)		7.78
Forfeited		(31,914	)		94.92
Outstanding at the end of the year		3,412,281			52.52		4.66
Exercisable at the end of the year		2,324,545			45.38		4.18

Schedule of Fair Value of Options Estimated on Grant Date

	December 31,
	2023	2022	2021
Volatility	56% – 58%	54% – 57%	50% – 55%
Expected term in years	3.78 – 5.23	3.78 – 4.56	3.67 – 4.61
Risk-free interest rate	3.37% – 4.22%	1.87% – 4.4%	0.43% – 1.11%
Estimated fair value of underlying ordinary shares	20.5 – 39.35	27.55 – 81.03	170.35 – 323.10
Dividend yield	0%	0%	0%

Schedule of Options Outstanding under 2011 Plan

		Outstanding			Exercisable
Exercise price	Number of share options		Weighted average remaining contractual life(in years)		Number of share options		Weighted average remaining contractual life(years)
$1.74-$5.15		275,414		1.87	275,414			1.87
$5.16-$11.81		305,106		4.53	305,106			4.3
$11.82-$15.62		526,063		5.02	525,313			5.02
$15.63 -$25.31		359,221		3.61	359,971			3.61
$25.32-$27.87		363,263		5.21	148,158			3.44
$27.88-$36.29		312,238		5.73	108,912			5.74
$36.30-$38.29		412,933		6.14	77,414			6.14
$38.30-$84.27		272,106		4.03	204,240			3.87
$84.28-$227.06		235,457		5.12	104,311			5.11
$227.07-$243.50		350,480		4.41	215,706			4.39
Total		3,412,281		4.66	2,324,545			4.18
Aggregate intrinsic value	$	22,065				22,052

Schedule of Status of RSU

	December 31, 2023
	Number of RSUs			Weighted- average grant date fair value
Outstanding at the beginning of the year		1,136,128			96.49
Granted		1,206,151			35.80
Vested		(595,882	)		79.38
Forfeited		(269,579	)		75.33
Outstanding at the end of the year		1,476,818			57.76

Schedule Of Fair Of Espp Weighted Average Assumptions

	December 31,
	2023		2022		2021
Volatility		66.4-97.6%		86.4-97.6%		86.0-86.4%
Expected term in years		0.5		0.5		0.5
Risk-free interest rate		4.24-4.96%		0.08-4.24%		0.03-0.08%
Estimated fair value of underlying ordinary shares		26.40-206.07		35.36-206.07		131.88-206.07
Dividend yield		0%		0%		0%

Schedule of Stock-Based Compensation Costs

	December 31,
	2023		2022		2021
Cost of revenue	$	2,497	$	2,520	$	1,436
Research and development		24,310		23,828		20,008
Sales and marketing		13,304		17,196		14,106
General and administrative		28,587		28,211		19,857
	$	68,698	$	71,755	$	55,407